Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saint Humic Acid is a China-based commercial supplier of humic acid- and fulvic acid-derived products serving agriculture, environmental protection, animal feed, and limited healthcare-related ingredient markets. The company describes itself as a research, development, and global distribution business founded in 2010 and operating as a sister company to Jing Feng Humic Acid. Its product portfolio includes humic acid, sodium humate, potassium humate, nitro humic acid, potassium fulvate, fulvic acid, and related derivatives. While the company markets certain "medical" or "pharmaceutical" humic acid products, available public information indicates it is primarily a specialty chemical and industrial/agricultural products company rather than a drug-development biotech or pharmaceutical company. Its business appears focused on manufacturing, formulation, and international sales rather than advancing a clinical therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saint Humic Acid.